CAS 13040-21-6

N-(3-hydroxyphenyl)acrylamide

Codes: OLMU-011

Application context (from source-drug indications)

Non-small cell lung cancerOlmutinib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Olmutinib	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

OlmutinibOptimised routesteps: 2total yield: 50.6 g (Olmutinib)

2,4-dichlorothieno[3,2-d]pyrimidine→4-(4-methylpiperazin-1-yl)aniline→N-(3-hydroxyphenyl)acrylamide→N-(3-((2-chlorothieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.